Matthew Wongchenko

Company: Genentech

Job title: Principal Scientific Manager

Seminars:

Investigating Biomarker Strategies for Patient Stratification for DDR Inhibitor Monotherapies 2:00 pm

• Review the predictive biomarkers that have been studied to identify patients most likely to respond to DDR inhibitor monotherapies • Assess the validity and reproducibility of patient selection biomarkers for approved monotherapies and apply these lessons to novel target monotherapies • Reflect on the clinical relevance of biomarkers and concerns regarding tumor resistanceRead more

day: Pre-Conference Day

Panel Discussion: Balancing Novel Biomarkers for Multiple Cancer Types for DDR Inhibitor Development 12:00 pm

• Can we repurpose biomarkers used by other areas of oncology? • What do we need to know to develop and validate biomarkers amongst the complexity of DDR pathways? • Are novel target specific biomarkers for every novel target a worthwhile pursuit or realistic goal? Should we aim for a universal DDR biomarker?Read more

day: Pre-Conference Day